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Deciphering the mechanisms by which Plasmodium parasites develop inside hepatocytes
is an important step toward the understanding of malaria pathogenesis. We propose that
the nature and the magnitude of the inflammatory response in the liver are key for the
establishment of the infection. Here, we used mice deficient in the multidrug resistance-2
gene (Mdr2−/−)-encoded phospholipid flippase leading to the development of liver
inflammation. Infection of Mdr2−/− mice with Plasmodium berghei ANKA (PbANKA)
sporozoites (SPZ) resulted in the blockade of hepatic exo-erythrocytic forms (EEFs) with
no further development into blood stage parasites. Interestingly, cultured primary
hepatocytes from mutant and wild-type mice are equally effective in supporting EEF
development. The abortive infection resulted in a long-lasting immunity in Mdr2−/− mice
against infectious SPZ where neutrophils and IL-6 appear as key effector components
along with CD8+ and CD4+ effector and central memory T cells. Inflammation-induced
breakdown of liver tolerance promotes anti-parasite immunity and provides new
approaches for the design of effective vaccines against malaria disease.
Keywords: CD8-CD4 T cells, inflammation, liver, malaria, vaccineINTRODUCTION
Malaria infection has two distinct phases in the mammalian host: a clinically silent pre-erythrocytic
phase that is required for the establishment of the infection, and an erythrocytic phase, responsible
for all the clinical symptoms of malaria. As the development of Plasmodium sporozoites (SPZ)
inside hepatocytes is an essential step before the onset of disease, the liver is an obligate tissue which
offers an ideal niche for transmitted SPZ to develop.
The liver is a body site where immunological tolerance mechanisms prevail (1). This property,
which has evolved to limit over-reactions of this tissue to the continuous flow of antigens and pro-
inflammatory stimuli originating from the intestine, represents an immunologic advantage to
pathogens that have elected the liver as the site for their development (2, 3). Tolerance elicited viaorg November 2020 | Volume 11 | Article 5855021
Grand et al. Hepatitis Impedes Malaria Infectionthe portal vein (4) seems to be mediated by Kupffer cells (KC) (5)
and was shown to be involved in tolerance to liver allografts, to
tumor metastases, and to the persistence of hepatitis B and C
viruses (6, 7). Cross-presentation of antigen in vitro by KC was
shown to inhibit T cell activation in an IL-10-dependent manner
(8) and to cause in vivo CD8 T cell apoptosis (9). In case of liver
transplants, allografts are spontaneously accepted with only low-
dose immune-suppression and induce tolerance for non-hepatic
co-transplanted allografts of the same donor. Although this
immuno-tolerogenic environment is favorable in the setting of
organ transplantation, it is detrimental in chronic infectious liver
diseases like hepatitis B or C, schistosomiasis, and malaria, or
tumorigenesis, leading to pathogen persistence and weak anti-
tumor effects (10). Other liver cells participate in tolerance
mechanisms as well. Liver sinusoidal endothelial cells were
demonstrated to promote CD8 T cell tolerance via decreased
expression of co-stimulatory molecules CD80 and CD86 (11)
and up-regulation of the checkpoint inhibitor PD-L1 (12).
Hepatic stellate cells, located between hepatocytes and liver
sinusoidal endothelial cells, have also been reported to be poor
antigen presenting cells and tolerogenic through the expansion
of regulatory T cells (13).
These findings suggest that during the establishment of
Plasmodium infection, the invasion and development of
infectious SPZ inside hepatocytes take advantage of the liver
tolerogenic environment. Understanding the immunological
mechanisms associated with the liver tissue is of paramount
importance during malaria infection since it acts as a bottleneck
to blood-stage infection and represents a potential site for
parasite and disease control with the development of effective
therapeutics and/or vaccines. Additionally, this tissue represents
the only non-lymphoid organ where priming of CD8 and CD4 T
cells can take place independently of lymphoid tissues (14). In
fact, it was observed that the development of SPZ into the EEFs
occurs in absence of any inflammatory reaction (15).
Importantly, reversal of the tolerance state into inflammation
was shown to result in an efficient adaptive immune response
and anti-parasite protection, a condition that was observed
during immunization with g-irradiated SPZ (15).
The liver tolerance can be reversed under inflammatory
conditions leading to the recruitment of leukocytes involved in
the innate and adaptive immunity. The purpose of this study is to
use a genetically engineered mouse model with a high
inflammatory environment to investigate if shifting liver tissue
homeostasis toward an inflammatory state would promote anti-
parasite immunity. Mice deficient in the multidrug resistance-2
gene (Mdr2−/−), which encodes the canalicular phospholipid
flippase leading to a complete absence of phospholipids from
bile, spontaneously develop liver injury with features resembling
human sclerosing cholangitis and low grade hepatitis (16). The
bile of these mice does not contain phosphatidylcholine, the
major phospholipid of the bile which serves to emulsify bile acids
secreted by hepatocytes and thereby attenuates their toxicity. The
Mdr2−/− mice, which have been exploited in a pioneering study
to demonstrate the relevance of inflammation for liver
carcinogenesis (16, 17), provide here a genuine tool to exploreFrontiers in Immunology | www.frontiersin.org 2the relationships between liver inflammatory processes and
immunity against liver stage Plasmodium infection.MATERIAL AND METHODS
Ethics Statement
All animal careandexperimentsdescribed in thepresent study involving
mice were conducted at the Institut Pasteur, approved by the “Comité
d’Éthique en ExpérimentationAnimale” (CETEA) (PermitNumberN°
dap180040 issued on 2018) and performed in compliance with
institutional guidelines and European regulations. A statement of
compliance with the French Government’s ethical and animal
experiment regulations was issued by the Ministère de l’Enseignement
Supérieur et de la Recherche under the number 00218.01.
Mice
Six- to eight-week-old female Mdr2 knock-out homozygous in
FVB and C57BL/6JRj genetic backgrounds were used for this
study, as well as the double knock-out Mdr2−/− IL-6−/− (C57BL/
6JRj). The WT FVB and C57BL/6JRj mice were used as controls.
Mdr2−/− (FVB) were obtained from Yu Wei (Department de
Virologie, Institut Pasteur) Mdr2−/− (C57BL/6JRj) and Mdr2−/−
IL-6−/− (C57BL/6JRj) were obtained from Jonathan Axelrod
(Goldyne Savad Institute of Gene Therapy, Hadassah Medical
Center, Israel) (18). WT FVB mice were purchased from Charles
River Laboratories and C57BL/6JRj mice were purchased from
Janvier Labs, France. Colonies of both Mdr2−/− (FVB), Mdr2−/−
(C57BL/6JRj), Mdr2−/−IL-6−/− (C57BL/6JRj) and WT FVB
mouse strains were maintained at the animal facility of Institut
Pasteur. FVB is an albino, inbred laboratory mouse strain that is
named after its susceptibility to Friend leukemia virus B. FVB/NJ
are commonly used for transgenic injection and have the H2q
MHC haplotype. Animals were housed with a 12-hour light-dark
cycle with standard chow and water.
Parasites and Mice Infection
Mice were infected with either PbNK65 or PbANKA GFP-
transgenic SPZ collected from salivary glands of infected
Anopheles stephensi. Infections were performed via i.v.
injection in the tail vein of either 102, 103, 104 or 5 × 104 SPZ
according to the experiments or by natural infection by
infectious mosquito bites. The natural infection was performed
by the exposure of mice to bites of 10 infected A. stephensi for
15 min. Mosquitoes were provided by the CEPIA (Centre
d’élevage, de production et d’infection des anopheles, Institut
Pasteur). Survival and parasitemia as determined by FACS using
Cytoflex cytometer (Beckman Coulter Life Sciences, Villepinte,
France) and the software FlowJo (FlowJo LLC, Ashland, OR,
USA) were then monitored daily, beginning day 4 p.i. Symptoms
associated with ECM in mouse models include coat ruffling, a
respiratory distress syndrome, a drop in body temperature, and
neurological signs such as paralysis, and coma, followed by
death. For ethical reasons, manifestation of signs such as coat
ruffling and reduced motor skills which represent a limit point,
constitutes a criterion for interrupting the experience.November 2020 | Volume 11 | Article 585502
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for Quantification of Parasite
Load and Cytokines
The livers of Mdr2−/− and WT mice infected with 104 SPZ of
PbANKA were surgically removed 4, 12, 24 and 40 h p.i.
respectively. Total RNAs were extracted from the liver samples
using the guanidinium–thiocyanate–phenol–chloroformmethod
(all from Invitrogen, Waltham, MA, USA). RNA was thereafter
reverse transcribed by PCR (temperature: 65°C for 5 min, 42°C
for 50min, 70°C for 15min) using 100USuperScriptTM II reverse
transcriptase (RT) (Invitrogen,Waltham,MA,USA), 40URNAse
Inhibitor and 2 mMoligo(dT) per sample. The expression levels of
diverse parasite and mouse transcripts were analyzed by real time
RT-qPCR using Power SYBR® Green PCR Master Mix (Applied
Biosystems Foster City, CA, USA) and various primer sets (Table
S1). All reactions were performed in the CFX96 Touch™ Real-
Time PCR Detection System (Bio-Rad Laboratories Inc.,
Hercules, CA, USA) (temperature: 50°C for 2 min, 95°C for
10 min, 40 cycles of 95°C for 15 s and 60°C for 1 min). The
relative abundance of the target RNAs in the liver was calculated
using the DCt method, and expressed as (2−DCt) × 104. The mouse
hypoxanthine phosphoribosyl transferase (HPRT) gene was used
as an internal control for the variation in input RNA amounts. A
no template control (NTC) was included to ensure that there was
no cross-contamination during sample preparation. The same
protocol was used for RNA extraction from isolated neutrophils
and hepatocytes.
Ex Vivo Microscopy for Quantification of
EEF in Mice Liver
The livers ofMdr2−/− andWTmicewere removed4, 12, 24 and 40h
respectively after being injected with 50,000 GFP-expressing
PbANKA SPZ. Livers were placed in PBS in a 35 mm imaging
dish with Polymer Coverslip Bottom (Ibidi GmbH, Gräfelfing,
Bayern, Germany) and observed using a Zeiss Axiovert (Zeiss,
Oberkochen, Germany) equipped with phase-contrast and
epifluorescence microscopy. EEF were counted on 20 fields
(objective × 10) and normalized by 10 mm2. Parasite size was
determined on microscopy pictures using the ImageJ software.
Culture and Infection of Mouse
Primary Hepatocytes
The livers of anesthetizedmice, injectedwith a solution of Ketamine/
Xylazine (Imalgene 1000/Rompun 2%), were perfused via the portal
vein with two solutions. First 50 ml of 37°C Hepes buffer (137 mM
NaCl, 2.68 mM KCl, 10 mM Hepes, 0.7 mM Na2HPO4)
complemented with penicillin/streptomycin (100 U/ml). Then with
50mlof 37°CWilliam’sEmedium(LonzaGroupGmbH,Waldshut-
Tiengen, Germany) containing 100 U/ml of type IV collagenase
(Worthington Biochemical Corporation., Lakewood, NJ, USA). The
perfusate was drained out of the body via the inferior vena cava,
which was cut immediately after starting perfusion. During both
perfusion periods, the inferior vena cava was clamped to inflate the
liver and the perfusion solution was warmed at 37°C using a water
bath.Thedigested liverwas then excised rapidly, the liver capsulewas
disrupted, and the hepatocytes were released by gently shaking theFrontiers in Immunology | www.frontiersin.org 3digested liver into completeWilliam’smediumE (10%FCS, 2mMof
L-Glutamin, 100 U/ml of Penicillin/Streptomycin, 1 mg/ml of
Aprotinin, 10 mg/ml of human Transferrin, 1 mg/ml of human
recombinant Insulin) (Sigma Aldrich, Saint-Louis, MO, USA). The
cell suspension was passed through a 100 µl nylon cell strainer
(Falcon® Thermo Fisher Scientific Inc, Brebière, France) and
washed and centrifuged three times at 50 g in complete William’s E
medium. The cells were resuspended, and viability was checked by
using the trypan blue exclusion method. An enrichment in living
hepatocytes was performed using a Percoll gradient: 5 ml of an 80%
isotonic Percoll solution (in PBS 1X) was applied at the bottom of a
14 ml Falcon and cells were resuspended in 5 ml of 40% isotonic
Percoll solution (in PBS 1×) and gently applied over the top of the
tube. The cell suspension was fractioned by centrifugation at 750g
during 20 min without brake at 20°C. After Percoll gradient
centrifugation, the live hepatocytes were collected at the border
between the two layers. Cells were washed two times in complete
William’sMedium and counted. Formicroscopy pictures (Figure 3)
60,000 cells were plated on µ-Slide 8 well plates (Ibidi GmbH,
Gräfelfing, Bayern, Germany). For co-culture assays between
15,000 and 20,000 cells were seeded onto a 96-well plate (TPP
Techno Plastic Products AG, Trasadingen, Switzerland) in
complete William’s E medium. The growth medium was replaced
3 to 5 h after isolation. The cells were cultured at 37°C and 5% CO2.
PbANKA GFP expressing parasites were obtained by dissecting
salivary glands from infected female A. stephensi mosquito SPZ
suspension in complete William’s E medium was added at a ratio
of SPZ/hepatocytesof 1/4 foreachwell 24hafterplating.Parasite liver
stage development was followed and quantified by counting the
whole well by fluorescent microscopy using a Zeiss Axiovert (Zeiss,
Oberkochen, Germany) microscope equipped with phase-contrast
and epifluorescence.
Flow Cytometric Analysis of Liver
Leukocytes
Liver resident leukocytes were obtained from naïve and infected
Mdr2−/− and WT mice 40 h p.i. Briefly, mice were lethally
anesthetized with a solution of Ketamine/Xylazine and mice livers
were perfused with 30 ml of PBS 1× to remove red blood cells and
circulating leukocytes. After the perfusion livers were digested in
vitro in a collagenaseD solution (0.05%) (RocheMolecular Systems
Inc., Branchburg, USA) at 37°C for 45min andmixed through a 70
mm cell strainer (Falcon® Thermo Fisher Scientific Inc, Brebière,
France). Cells were washed in PBS and purified by Percoll gradient:
5 ml of an 80% isotonic Percoll solution (in PBS 1×) was applied at
the bottom of a 14 ml Falcon and cells were resuspended in 5 ml of
40% isotonic Percoll solution (in PBS 1×) and gently applied over
the top of the tube. The cell suspension was fractioned by
centrifugation at 3,000 rpm during 30 min without brake at 4°C.
After Percoll gradient centrifugation, the leukocytes were collected
at the border between the two layers. Cells werewashed in coldPBS,
resuspended in FACS buffer containing 2% Fetal calf serum (FCS)
and 0.01% sodium azide and counted. Obtained liver leukocytes
were stained for FACS analysis according to standard protocols in a
FACS buffer with the following antibodies: FITC-labeled CD4
(clone H129.19), PerCP-labeled anti-CD8 (clone (53–6.7),November 2020 | Volume 11 | Article 585502
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(clone 1A8), FITC-labeled anti-B220 (clone RA3-6B2), PE-
labeled anti-CD11c (clone HL3), PerCP-labeled anti-CD19, APC-
Cy 7 labeled anti-CD3 (clone 145-2C11), PeCy7-labeled anti-CD44
(clone IM7), PE-labeled anti-CD69 (clone H1 2F3), BV605 labeled
anti-CD62L (clone MEL-14), BV421 hamster anti-mouse KLRG1
(clone 2F1) and FITC/PE/PerCP or Alexa fluor 647-labeled anti-
CD45 (clone 30-F11). All antibodies were purchased from BD
Biosciences, San Jose,CA,USA.Cellswerewashedandresuspended
in FACS buffer before analysis. A total of 5 × 105 living or fixed cells
were analyzed using a Cytoflex cytometer (Beckman Coulter Life
Sciences, Villepinte, France) and the software FlowJo (FlowJo LLC,
Ashland, OR, USA).
In Vitro Co-Cultures
WTFVBprimary hepatocytes were isolated as described above and
seeded in a 96-well plate, between15,000 and 20,000 cells perwell in
complete William’s E medium. HepG2 cell line, routinely tested
negative formycoplasma (PlasmoTest, InvivoGen, SanDiego, CA),
were thawed in completeDMEMmediumcontaining 10%FCSand
2% Streptomycin/Neomycin and plated at a concentration of 4 ×
104 cells per well. The day after plating, neutrophils were isolated
from the bone marrow of Mdr2−/− or control mice using magnetic
beads based on negative selection using theNeutrophil Isolation kit
(MACS, Miltenyi Biotec GmbH Bergisch Gladbach, Germany).
Resident liver leukocytes were isolated fromMdr2−/− andWTFVB
mice as described previously. Both liver leukocytes or neutrophils
were added to hepatocyte cultures at different ratios leukocyte/
hepatocytes (1/10, 1/100 and1/1,000) 2 h before the additionof SPZ
into the cultures. Parasite liver stage development was followed and
quantified by counting the whole well by fluorescent microscopy
using a Zeiss Axiovert microscope equipped with phase-contrast
and epifluorescence.
In Vivo Neutrophil Depletion
Forneutrophildepletion,Mdr2−/−micewere injectedwith250mgof
a rat anti-mouse neutrophil depleting antibody (anti Ly6G rat
monoclonal antibody, clone Nimp-R14 which was shown to
recognize the same neutrophil population as the anti-Ly6B 7/4
mAbs.) provided by G. Milon (Institut Pasteur) the day before the
infection with 104 GPF-expressing PbANKA. Control mice were
injectedwith anunrelated IgG2b isotype control. The depletionwas
assessed byflowcytometry, on blood samples collected from the tail
vein of treated and untreated mice. Neutrophils were counter-
stained using an FITC-conjugated anti-neutrophil 7/4 antibody
which recognizesLy6GBsurfaceantigen. Inaddition, asneutrophils
are the major side scatter-high (SSChigh) leukocyte population,
treatment with a neutrophil-depleting antibody induces marked
reduction in the number of SSChigh cells.
Treatment of Mice With Murine
Recombinant IL-6
The murine recombinant IL-6 (ImmunoTools GmbH, Friesoythe,
Germany) was administered i.v. at various doses, 1, 5, and 10 mg/
mouse toWT FVBmice four times: 1 day before, 1 h before, 1 day,
and 2 days after infection with PbANKA SPZ. Control mice were
injected with PBS.Frontiers in Immunology | www.frontiersin.org 4Detection of Anti-Parasite Specific
IgG Antibodies
To detect parasite-specific antibodies, 96-well plates (Nunc-
immuno plate; Thermo Scientific, Rockford, IL) were coated
with parasite protein extract from isolated SPZ from A. stephensi
salivary glands in carbonate buffer, pH 9.6, for 2 h at 37 °C. After
the plates were saturated with 1% (w/v) pork gelatine, each
serum sample was assayed at serial dilutions and incubated
overnight for 2 h at 37°C. Specific binding was detected using
horseradish peroxydase (HRP)-conjugated goat anti-mouse
secondary antibody (Cell Signaling technology®, Danvers,
MA) followed by the addition of o-phenylenediamine
dihydrochloride (OPD) substrate (Sigma-Aldrich; St. Louis,
MO). Hydrogen chloride (HCl) 1 N was used to block the
reaction. The optical density (OD) was read at 490–655 nm.
Each sample was tested against non-immune serum and PBS as
background controls.
Statistical Analysis
All data were analyzed using Prism 5.0 software (GraphPad
Software, San Diego, USA). Unpaired data between two groups at
a specific time point were analyzed by a Mann–Whitney test for
nonparametric analysis.Kaplan–Meier survival plotswere analyzed
using a Mantel–Cox test. A p-value <0.05 was considered to be
statistically significant. All experiments were replicated several
times as indicated in the figure legends.RESULTS
Parasite Development Is Blocked
in the Liver of Mdr2−/− Mice
Mice were exposed to infectious mosquito bites delivering either
PbANKA or PbNK65, two lethal strains of parasites, which cause
experimental cerebral malaria (ECM) (19) or hyperparasitemia
and anemia (20, 21), respectively. Figures 1A, B show that in
contrast to WT mice, Mdr2−/− mice did not develop blood stage
infections with both parasites. All WT mice infected with both
parasites died, whereas all Mdr2−/− mice survived the infection
(Figures 1C, D).
To control the effect of the actual amount of inoculated SPZ,
infection with various doses of isolated parasites (102, 103 and 104
SPZ, respectively) from themosquito salivary glands showed that in
contrast toWTFVBmice, infectionofMdr2−/−micewithPbANKA
SPZ at all doses, except at the highest dose where a transient
parasitemia was noticed (Supplementary Results: Figure 1E),
resulted in a complete blockade of the parasite in the liver
(Supplementary Results: Figures 1A, C, E). The survival curves
are in agreementwith those of parasitemia and none of theMdr2−/−
mice died fromECMexcept one out of six which died fromECMat
the dose of 104 SPZ (Supplementary Results: Figures 1B, D, F). In
comparison, allWTFVBmice infectedwith 102 SPZ and half of the
mice which received the dose of 103 SPZ died from
hyperparasitemia but not CM, whereas the other half of the mice
which were infected with 103 SPZ and 80% of the mice which
received the dose of 104 SPZ died from CM (SupplementaryNovember 2020 | Volume 11 | Article 585502
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with PbNK65 at the same range of doses did not result in any
infection and all mice survived the infection (Supplementary
Results: Figures 1G, I, K), in contrast to WT mice which,
depending on the dose of the inoculum, developed parasitemia
and at the highest dose of 104 SPZ all mice developed parasitemia
and ultimately died from hyperparasitemia and anemia
(Supplementary Results: Figures 1H, J, L).
To the best of our knowledge, no previous reports exist on
infections of Mdr2−/− mice with P. berghei parasites. Here, we
provide evidence that, in contrast to SPZ infection, these mice
support perfectly well PbANKA growth when inoculated with
blood stage parasites, indicating that the liver constitutes a trueFrontiers in Immunology | www.frontiersin.org 5barrier for SPZ development. This is clearly shown in
Supplementary Results: Figure 2 where both parasitemia
(Supplementary Results: Figure 2A), except at days 13–15
where some differences were observed, and survival rates
(Supplementary Results: Figure 2B) where indistinguishable
between WT FVB and Mdr2−/− mice. It can also be inferred that
the inflammatory environment in these animals is not simply
suppressive of asexual parasite growth but rather represents a
failure to complete liver stage development.
These data prompted us to quantitatively assess the parasite
load in the liver. Female WT and Mdr2−/− mice were inoculated
intravenously (iv) with 104 SPZ and liver samples collected at 4,




FIGURE 1 | Mdr2−/− mice do not develop blood stage parasites. Parasitemia and survival of infected WT FVB and Mdr2−/− mice. Six-week-old WT FVB and Mdr2−/− mice
(n = 6 per group) were naturally infected by the exposure to bites of 10 Anopheles infected with PbANKA (A, C) or PbNK65 (B, D). Survival rate (Kaplan–Meier survival rates,
Mantel–Cox test **p = 0.0012; ***p = 0.0009) and parasitemia were recorded over time. Results are from two independent experiments. (E) Real time qPCR (RT-qPCR)
quantification of parasite ribosomal RNA 18s into 6-week-old female WT FVB and Mdr2-/- mice 4, 12, 24 and 40 h after infection with 104 SPZ (n = 5 per group). RT-qPCR
was performed using standard SyberGreen protocols on total liver RNA. (F) Quantification by ex vivomicroscopy of exoerythrocytic forms (EEFs) in livers of 6-week-old
female WT FVB and Mdr2−/− mice injected i.v. with 5 × 104 PbANKA SPZ 4, 12, 24 and 40 h post infection (n = 5 per group). EEFs were counted on 20 fields (objective × 10)
and normalized by 10 mm2 of liver section. Results are from two independent experiments (Mann–Whitney test; *p < 0.05; **p < 0.01; ***p < 0.001).November 2020 | Volume 11 | Article 585502
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the parasite was detected at 4 h and then progressed afterwards
through 48 h p.i, the parasite was just present at the limit
of detection throughout the entire pre-erythrocytic phase in
Mdr2−/− mice (Figure 1E). In parallel, we examined the
abundance of exoerythrocytic forms (EEFs) in the liver of WT
and Mdr2−/− mice inoculated with 5 × 104 PbANKA SPZ by
fluorescence microscopy at the same time points as in Figure 1E.
As shown in Figure 1F, EEFs were readily observed at 4h p.i. and
decreased progressively over time in WT mice. Only about half
number of EEFs were detected in Mdr2−/− mice at 4 h p.i, when
compared to WT mice, and then drastically decreased up to 48 h
p.i. Altogether, these results suggest that parasites are blocked in
the liver of Mdr2−/− mice at early time points right after
infection, and that clearance of SPZ and liver stages are both
likely to be targeted by immune effector mechanisms.
Isolated Primary Hepatocytes From
WT and Mdr2−/− Mice Are Equally
Able to Support EEF Development
Previous in vivo results showed an impairment of parasite
development in the livers of Mdr2−/− mice. To assess whether
hepatocytes from WT and Mdr2−/− mice display a differential
susceptibility to infection by SPZ, primary hepatocytes from WT
and Mdr2−/− mice were isolated and infected with PbANKA SPZ
in vitro. As shown in Figure 2, Pb parasites can invade and
develop inside primary hepatocytes isolated from WT and
Mdr2−/− hepatocytes with the same efficiency both in terms of
parasite size (Figure 2A) or parasite counts (Figure 2B). The
Mdr2−/− mutation does not affect the ability of hepatocytes to
support EEF development. These results suggest that the parasite
development failure in the liver of Mdr2−/− mice is more likely
due to an active induction of immunity rather than to the
inability of mutant hepatocytes to get infected.
Cellular Infiltrates in Naïve and
Infected Mdr2−/− Mice
To examine the changes in cellular infiltrates that may be caused
by themdr2mutation, we carried out a cell phenotyping analysis
on perfused liver samples collected from naïve mice or 40 h p.i
from mice inoculated i.v with 104 SPZ. The most notable results
showed, except for the CD45+ cell population, elevated
percentage of CD8+, Ly6G+, F4/80+, and CD11c+ in naïve
Mdr2−/− mice as compared to WT mice (Figure 3A). Of note,
these differences persisted in SPZ-infected mice with higher
proportions in mutant mice. In naïve mice, total cell counts
follow the same pattern in that the numbers of CD8+, Ly6G+, F4/
80+, CD11C+, and B220+ CD19+ cells were found to be more
elevated in Mdr2−/− mice as compared to WT mice (Figure 3B).
However, in infected mice, these differences were wiped out.
These data suggest that the rapid blockade of SPZ development
in the liver of Mdr2−/− mice is very likely due to the higher
prevalence of innate and adaptive immune cells which may act
coordinately to arrest parasite developmental progression.
As neutrophils are among innate immune cells that represent
a first line of defense against pathogens, one of the candidatesFrontiers in Immunology | www.frontiersin.org 6A
B
C
FIGURE 2 | Isolated primary hepatocytes from WT and Mdr2−/− mice are
equally able to support EEF development. Hepatocytes were isolated from 6-
week-old female mice by a two steps perfusion of the entire liver in vivo with
collagenase IV and infected in vitro with PbANKA SPZ. (A) Representative
EEFs (in green) shown by fluorescence microscopy 24 and 48 h p.i. of in vitro
infected hepatocytes from WT FVB and Mdr2−/− mice by fluorescence
microscopy (Objective × 40). (B) Quantitative representation of EEFs counted
by fluorescence microscopy on 20 fields (objective × 10). Counts were
performed on eight wells per condition (Mann Whitney test; ns p > 0.05).
(C) Quantitative representation of EEFs size. Diameters of parasites were
measured using Image J software (n = 6 per group) (Mann Whitney test; ns
p > 0.05). Bar graphs represent the mean ± SEM. Experiments were
replicated three times.November 2020 | Volume 11 | Article 585502
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CXCL5, a powerful attractant for neutrophils which acts via
CXCR2 receptor (22, 23). As shown in Figure 3C, higher levels
of CXCL5 transcripts were observed in Mdr2−/− mice as
compared to WT FVB mice both in naïve mice and at 40 h p.i.Frontiers in Immunology | www.frontiersin.org 7CXCR2 was differentially expressed only in naïve mice and
became similarly expressed by the two mouse strains at 40 h
p.i. (Figure 3D). In addition, among a large panel of cytokines
measured, only IL-6 levels were also found to be highly expressed




FIGURE 3 | Patterns of resident liver leukocytes are differentially regulated in Mdr2−/− mice. Livers of 6-week-old female WT FVB and Mdr2−/− mice were harvested
from naive mice and 40 h p.i. with 104 PbANKA SPZ (n = 6 per group). Leukocytes present in liver tissue were analyzed using the following markers: CD45, CD4,
CD8, Ly6G, F4/80, CD11c, B220 and CD19. Results are expressed in percentage of positive cells among CD45+ cells (A) or in absolute cell number (B). Results are
representative for three independent experiments (Mann–Whitney test; *p < 0.05; **p < 0.01; ***p < 0.001). (C) Neutrophil chemoattractant chemokines and
chemokine receptors and IL-6 are up-regulated in Mdr2−/− mouse livers. Quantitative analysis by RT-qPCR of CXCL5 (B), CXCR2 (D) and IL-6 (E) on total liver
mRNA extracted from 6-week-old female WT FVB and Mdr2−/− uninfected or 40 h p.i. with 104 PbANKA SPZ (n = 6 per group). Results are representative of three
independent experiments (Mann–Whitney test; *p < 0.05; **p < 0.01; ***p < 0.001).November 2020 | Volume 11 | Article 585502
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that IL-6 production was associated with a higher prevalence of
neutrophils in Mdr2−/− mice and may act in tandem to
clear parasites.
Intra-Hepatocyte Parasite Development in
Mdr2−/− Mice Is Impaired by Neutrophils
To test whether leukocytes interfere with infection of hepatocytes,
resident leukocytes inMdr2−/− livers were isolated and co-cultured
with primary hepatocytes isolated from WT FVB control mice at
different ratios, two hours before infection with PbANKASPZ.WT
FVBhepatocytes alone or co-culturedwith liver resident leukocytes
from the samemouse strainwere used as controls. Interestingly, the
infection of WT FVB hepatocytes co-cultured with Mdr2−/−
leukocytes, as reflected by EEF counts at 40 h p.i., was
significantly less efficiently infected than the infection in the
controls whatever the leukocyte ratios (Figure 4A). This was
reflected by a reduction by 87% of EEF counts at a Mdr2−/−
leukocyte/FVB hepatocyte ratio of 1 to 1,000. These data suggest
that liver leukocytes of Mdr2−/−mice interfere with the infection of
primary WT hepatocytes in vitro.
In order to explore further the specific contribution of innate
immune cell sub-populations in the decrease of infection
efficiency by Mdr2−/− mouse leukocytes, co-cultures wereFrontiers in Immunology | www.frontiersin.org 8performed using neutrophils, a cell population found to be
more prevalent in the livers of Mdr2−/− mice (Figure 3B).
Interestingly, we observed a significant decrease of EEF counts
when ex vivo primary WT FVB hepatocytes were co-cultured
with neutrophils isolated from Mdr2−/− mice, but not with those
from WT FVB mice (Figure 4B). Furthermore, a significant
decrease of EEF counts was observed when HepG2 cells were co-
cultured with neutrophils isolated from Mdr2−/− mice at an
Mdr2−/− leukocyte/HepG2 hepatoma ratio of 1 to 10 (Figure
4C). Comparatively, Mdr2−/− mouse neutrophils inhibited more
effectively the infection of primary hepatocytes than of HepG2
cells. The ability of neutrophils, isolated from Mdr2−/− mice, to
dampen the infection in vitro suggests that these cells are key
players in the developmental defect of the parasite in this model.
To address the relevance of neutrophils in the rapid clearance
of Plasmodium parasites in the liver in vivo, Mdr2−/− mice were
treated with an anti-neutrophil depleting antibody before they
were infected with 104 PbANKA SPZ. As shown in Figure 4D,
measurement of parasite load in the liver at 24 h p.i indicated a
reversal in the development of the parasite in neutrophil-
depleted mice reaching almost similar levels as in WT FVB
mice as compared to undetectable parasites in the control
untreated Mdr2−/− mice. Efficacy of neutrophil depletion was
assessed in the blood of treated mice by flow cytometry andA B
D E
C
FIGURE 4 | Impairement by neutrophils of intra-hepatic parasite development in Mdr2-/- mice. Infection of primary hepatocytes (PH) isolated from naïve 6-week-old
female WT FVB mice co-cultured with liver resident leukocytes (A) or with neutrophils isolated from the bone marrow of naïve 6-week-old female WT FVB and
Mdr2-/- mice (B). In parallel, Infected HepG2 cell line was co-cultured with bone marrow neutrophils isolated from naïve 6-week-old female WT FVB and Mdr2-/-
mice. 1/10, 1/100 and 1/1000 reflect the ratios of leucocytes over hepatocytes (A) and neutrophils (PMN) over hepatocytes (B, C). The number of EEFs was
determined in five independent wells per condition using fluorescence microscopy (objective × 20) at 40 h p.i. with PbANKA. Results are representative of three
independent experiments. (D) Measurement of EEFs by fluorescence microscopy (objective × 10) in the liver of WT FVB, and Mdr2−/− controls and in neutrophil
depleted-Mdr2−/− mice 24 h p.i. with 104 PbANKA SPZ (Mann–Whitney test; *p < 0.05; **p < 0.01; ***p < 0.001). (E) Assessment of neutrophil depletion efficacy:
FACS dot plot analysis in the blood of 6-week-old female Mdr2−/− mice treated with the neutrophil depleting antibody anti-Ly6G or with an irrelevant antibody.
Neutrophils are stained using CD45 and Ly6G markers. PH, primary hepatocyte; PMN, polymorphonuclear cells.November 2020 | Volume 11 | Article 585502
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untreated mice (Figure 4E). These data provide evidence that
neutrophils are key players in blocking EEF development in vivo
in infected Mdr2−/− mice.
Reversal of Mdr2−/− Associated Infection
Phenotype in IL-6-Deficient Mice
At this point, it is tempting to postulate from the combined data
obtained inFigures3 and4 thatneutrophilsmay act in concertwith
IL-6 to ensure parasite clearance in the liver of Mdr2−/− mice. We
first assessed IL-6 expression in the liver before and 40h after SPZ
inoculation.As shown inFigure 5A, basal levels tend tobehigher in
total liver tissue of Mdr2−/− mice and while IL-6 was significantly
down-regulated in infectedWTFVBmice, therewas adramatic up-
regulation of IL-6 in the liver of infected Mdr2−/− mice. This
indicates that down-regulation of IL-6 by WT parasites which we
observed before (24) was buffered and reversed upon themdr2 gene
deletion and the pro-inflammatory environment that ensues. In an
attempt to identify the cellular source of IL-6 in Mdr2−/− livers, we
determined the expression of IL-6 in isolated hepatocytes and
neutrophils fromWT FVB and Mdr2−/− mice, before and 40 h p.iFrontiers in Immunology | www.frontiersin.org 9(Figure 5A). Interestingly, there is no significant differences in IL-6
expression in isolated hepatocytes from WT FVB and Mdr2−/−
before and40hp.i. (Figure 5A), suggesting that hepatocytesdidnot
contribute to the upregulation of IL-6 observed in Mdr2−/− mice
during infection. In contrast, we observed a significant increase of
IL-6 expression in neutrophils isolated fromMdr2−/− bonemarrow
before and 40 h p.i. compared toWTFVBneutrophils (Figure 5A).
In these experiments, neutrophils from the bonemarrowwere used
because of the paucity of neutrophils isolated from the livers which
didnot allowus toperformexploitableRT-PCRanalysis. This result
strongly suggests that IL-6+ neutrophils play a critical role in
controlling parasite development in the liver of Mdr2−/− mice.
To test the relevance of IL-6 in the elimination of the parasite in
the liver of infected Mdr2−/− mice, we compared the parasite
development in WT (FVB) and WT (C57BL/6) mice to Mdr2−/−
(C57BL/6) and Mdr2 IL-6 (C57BL/6) double-knockout
(Mdr2−/−IL-6−/−) mice. As shown in Figure 5B, while the parasite
develops perfectly well in WT C57BL/6 mice (open circles), there
was a strongly reduced development of the parasite in the liver of
C57BL/6Mdr2−/−mice (open squares), a phenotype that is slightly
less pronounced than that observed in WT FVB Mdr2−/− miceA B
DC
FIGURE 5 | IL-6 is essential for the clearance of the parasite in Mdr2−/− and is sufficient to abrogate parasite development in WT mice. (A) Quantification of IL-6 in
total liver mRNA by RT-qPCR in isolated primary hepatocytes and in sorted bone marrow neutrophils of 6-week-old female WT FVB and Mdr2−/− (FVB) mice naive
and infected with 104 PbANKA SPZ (Mann–Whitney test; *p < 0.05; **p < 0.01; ***p < 0.001). (B) Parasitemia of infected 6-week-old female WT FVB, C57BL/6,
Mdr2−/− (FVB), Mdr2−/− (C57BL/6) and Mdr2−/−IL-6−/− (C57BL/6) mice inoculated with 104 PbANKA SPZ (n = 6 per group) were recorded over time. To highlight the
subtle differences in parasitemia between different groups of mice, the insert represents the parasitemia between days 4 and 7 p.i. expressed in log scale. The
asterisks indicate that significant differences exist between Mdr2−/−IL-6−/− (C57BL/6) and Mdr2−/− (C57BL/6) groups using the Mann–Whitney test (*p < 0.05).
(C, D) Parasitemia and survival of 6-week-old female WT FVB mice (n = 6 per group) treated with several doses (1, 5, and 10 mg/mouse) of murine recombinant IL-6
(rmIL-6) and infected with 104 PbANKA SPZ. Control mice were injected with PBS. (D) Survival rate was recorded over time (Kaplan–Meier survival plot, Mantel–Cox
test **p < 0.0061, ***p = 0.001). Results are from two independent experiments.November 2020 | Volume 11 | Article 585502
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−IL-6−/−mice (filled triangles) was partly reversed and parasitemia
tended to reach that of WT C57BL/6 mice (open circles). To
highlight the differences in parasitemia between different groups
ofmice, results were expressed in log scale as it appears in the insert
of Figure 5B. This reversal in the infection phenotype consecutive
to IL-6 deficiency clearly demonstrates that the impaired parasite
development in the liver ofMdr2−/−mice is directly associated with
the up-regulationof IL-6production and strongly suggests that IL-6
represents a key anti-parasite cytokine in these mice.
Abrogation of Parasite Liver Stage
Development Upon Treatment With
Recombinant IL-6 Which Recapitulates the
Entire Phenotype of Mdr2−/− Mice With
Regard to the Control of Parasite Infection
To provide direct evidence that IL-6 could recapitulate the strong
pro-inflammatory response induced by LPS (data not shown), WT
WTFVBmice received recombinantmurine IL-6 (rmIL-6) at doses
of 1, 5 and10mg (i.p) administeredonedaybefore, the sameday and
two consecutive days after SPZ inoculation. Parasitemia was
inhibited in a dose-dependent manner with a complete
abrogation at 10 mg/mouse (Figure 5C). Survival curves showed
similar patterns as parasitemiawith a 40% survival at a dose of 5mg/
mouse and 100% survival at a dose of 10 mg/mouse (Figure 5D).
These data demonstrate that elicitation of IL-6 early during liver
infection completely abrogates parasite growth.
Since IL-6 was found to represent the key mechanism by
which Mdr2−/− mice control the parasite infection, we postulated
that treatment with IL-6 when mice are inoculated with
PbANKA SPZs would not only prevent primary infections but
also promote the development of a long-lasting anti-parasite
protection. WT FVB mice were treated with 10 mg IL-6 one day
before, the same day, and two consecutive days after inoculation
of 104 SPZs (Figure 6A). Mice which did not receive IL-6
developed parasitemia (Figure 6B) and died from ECM
(Figure 6C, control group 1), whereas IL-6-treated mice did
not show any parasitemia and all survived ECM (Figures 6B, C).
Protected mice, challenged at day 10 with the same dose of SPZs
(Figure 6A) did not develop any parasitemia (Figure 6B) and all
survived, whereas control mice developed parasitemia and all
died from ECM at day 16 (Figures 6B, C, control group 2). The
same mice which survived after two SPZ infection episodes were
challenged at day 18 with a higher dose of 5 × 104 SPZs. While all
mice infected with this large dose developed parasitemia and
died, repeatedly infected IL-6 treated mice remained parasite
free. These data demonstrate that the presence of IL-6 during the
pre-erythrocytic phase is able to protect mice from infection,
possibly conferring a long-lasting anti-parasite immunity.
Inoculation of SPZ in Mdr2−/− Mice
Results in a Robust T Cell Memory
and Antibody Responses
In addition to neutrophils which represent a first barrier of
defense against infections, we decided to investigate whether the
abortive development of SPZ into blood stage parasites inFrontiers in Immunology | www.frontiersin.org 10MDR2−/− mice will result in adaptive immune protection
against repetitive and higher doses of inoculated SPZ. A
protocol of immunization shown in Supplementary Results:
Figure 3A represents four groups of mice: naïve mice, primed
mice which received one single dose of 104 SPZ and two
challenged groups of mice which received two additional
injections of 104 (group 1) and 105 SPZ (group 2), respectively,
at 10 days interval. Parasitemia (Supplementary Results: Figure
3B) and survival rates (Supplementary Results: Figure 3C) were
determined over time, and 3 months later, mice were sacrificed,
and anti-SPZ antibodies were measured (Supplementary
Results: Figure 3D). It appears that, except from occasional
breakthroughs toward blood stage (Supplementary Results:A
B
C
FIGURE 6 | IL-6 alone recapitulates the entire phenotype of Mdr2−/− mice
with regard to the control of parasite infection. (A) Schematic representation
of the experimental procedure. Six-week-old WT FVB mice (n = 6) were
treated with recombinant murine IL-6 (rmIL-6) and infected with 104 PbANKA
SPZs. The same mice were challenged with 104 and 5 × 104 PbANKA SPZs
at days 10 and 18 p.i. Non-treated six week-old WT FVB mice (n = 6 per
group) were infected and used as controls for D10 and D18 challenges.
Parasitemia (B) and Survival rate was recorded over time (Kaplan–Meier
survival rates, Mantel–Cox test **0.0013 < p < 0.0053) (C). Data are
representative of three independent experiments.November 2020 | Volume 11 | Article 585502
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observed but ultimately cleared the parasite. The infected mice
remained refractory to infection even at challenges with the high
dose of 105 SPZ. At the end of the experiment, 90 days after the
initial infection, measurement of anti-SPZ specific IgG
antibodies indicated that these remained at a high level and
were elicited in a dose dependent fashion (Supplementary
Results: Figure 3D).
In parallel, we examined whether this immunization protocol
resulted in an increased number of antigen specific T cells with
effector function which, in addition to antibodies, could act to clear
the infection. It iswell established that about 90%of the effector cells
die during the 1–2 week long contraction phase, leaving a residual
population of long-lived effector and central memory T cells (25,
26). The total number of CD3+ CD8+ andCD3+ CD4+ T cells gated
onCD45+ cells (Figures 7A,B)was found to be increasedmostly in
challenged Mdr2−/− mice with no difference between 104 and 105
SPZ doses (Figures 7Cf, Dp). One of the changes in the cell surface
following T cell activation consists of the upregulation of CD44.
Gating of the CD3+CD8+ T cell population on the CD44 activation
marker (Figure 7A) revealed an increased absolute number of
CD8+ (Figure 7Cg) and CD4+ T cells (Figure 7Dq) in Mdr2−/−
challengedmice as compared to naïveMdr2−/−mice, again with no
significant difference between 104 and 105 SPZ doses. A gating
strategy based on the expression of CD44, CD69, and CD62L cell
surface markers resulted in two distinct CD4 and CD8 T cell
populations, namely CD44+ CD69− CD62L+ believed to be
central memory T cells (Tcm) and CD44+ CD69− CD62L−
identified as effector memory T cells (Tem). Challenged mice
showed that although percentage of CD8+ Tcm (Figure 7Cc) and
CD8+Tem (Figure 7Cd) cell populations decreased as compared to
control mice, there was no significant difference in absolute cell
numbers (Figures7Ch, i).Analysis ofmemoryT cells amongCD4+
T cells showed that only CD4+ Tcm cell population (Figure 7Dr)
expanded in challenged Mdr2−/− mice. A gating strategy, based on
the expression of CD44, CD69, CD62L, and KLRG1 (Figures 7A,
B), revealed a distinct CD8+ T cell population CD44hi CD69+
CD62L− KLRG1−, believed to be liver-resident memory T cells
(Trm). Analysis of Trm cells showed that in infectedMdr2−/−mice
which received one dose of 10,000 SPZ (primed mice group), we
observed an expansion of CD8+ (Figure 7Cj) and CD4+ (Figure
7Dt) Trm cell populations, in terms of absolute cell number,
significantly higher than in control mice. Interestingly, in
challenged Mdr2−/− groups where mice received two additional
doses of 10,000 SPZ (group 1) and 50,000 SPZ (group 2), we
observed a dramatic expansion in terms of absolute number of
CD8+ (Figure 7Cj) and CD4+ (Figure 7Dt) Trm cell populations.
These data suggest that although EEFs in infected Mdr2−/−
mice do not persist more than 24 h in the liver, a priming of T
cells nonetheless occurred, giving rise to populations of CD8+
and CD4+ Tem, Tcm, and Trm cells in parallel with a potent
anti-SPZ antibody response. These results are also consistent
with the idea that the creation of an inflammatory environment
in the liver is deleterious to the parasite and creates the
conditions for the establishment of an anti-parasite
immune memory.Frontiers in Immunology | www.frontiersin.org 11DISCUSSION
In this study, we demonstrate a clear phenotypic difference in the
Plasmodium berghei parasite development between age and sex
matched Mdr2−/− mice and WT mice, and this was replicated
with the same mutation in two genetic backgrounds, WT FVB
and C57BL/6. This is in agreement with our hypothesis that liver
inflammation potentially blocks the development of the
Plasmodium liver stage by shifting the immunologically
tolerant environment in the liver towards an effective anti-
parasite immunity.
Constantly challenged by gut-derived pro-inflammatory
stimuli, a set of mechanisms has been developed in the liver to
ensure a state of tolerance. Liver hematopoietic cells as well as
parenchymal cells contribute to the establishment of this
tolerogenic environment. Both in humans and in mice,
intrahepatic dendritic cells (DCs) exhibit unique properties
distinct from those of extrahepatic DCs, as they display an
immature phenotype with low expression level of co-stimulatory
andMHC II molecules, reduced endocytic activity and production
of anti-inflammatory prostaglandin E2 (27). As a result,
intrahepatic DCs are poor stimulators of T cells (28) via the
production of IL-10 and induction of regulatory T cells (10, 29).
During malaria infection, when inoculated SPZs reach the liver,
additional mechanisms are initiated including the increased up-
regulationby the abundant circumsporozoiteproteinof cyclicAMP
in traversed Kupffer cells (KC), which in turn inhibits the assembly
of the NADPH oxidase (30). This results in the blockade of reactive
oxygen species, a potent innate defense mechanism required to kill
the parasite (30). Traversal of KC by SPZs, in addition to blocking
the respiratory burst, was also shown to generate an anti-
inflammatory cytokine profile (31). In another study, exposure of
KC to infectious SPZ down-modulated MHC class I expression,
inhibited IL-12p40 secretion, and resulted in reduced antigen
presenting function (32). Disruption of the liver homeostasis
would create the conditions that lead to the reversal of the
tolerogenic conditions and the killing of the parasite.
In this study, we addressed this possibility by using a mouse
model where a genetic defect in the Mdr2 gene creates
inflammatory conditions in the liver. In support of our
hypothesis, in contrast to WT FVB mice, injected SPZ were
blocked early in their development in the liver of Mdr2−/− mice.
Over the years, Mdr2−/− mice models were extensively studied as
they provided a tool for studying cholestasis and hepatocellular
carcinoma, we first suspected an intrinsic defect of hepatocytes to
support parasite development. This turned out not to be the case,
since ex vivo cultures of primary hepatocytes from Mdr2−/− and
WT FVB mice in the presence of SPZ generated equivalent EEF
counts. We then ascribed defect in the parasite development in
Mdr2−/− mice to a possible control by the pro-inflammatory
tissue environment. The phenotypic manifestations of the
Mdr2−/− mutation are strain-dependent. Initially, the mutation
was introduced in the WT FVB mouse strain (Mdr2−/− FVB),
and more recently this mutation was transferred into the C57BL/
6 genetic background (33) and this study demonstrated
significantly retarded hepatocellular carcinoma developmentNovember 2020 | Volume 11 | Article 585502
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age in Mdr2−/− C57BL/6 mice. Accordingly, the more
pronounced inflammatory response in Mdr2−/− FVB mice was
correlated with higher infiltration of immune cells including
neutrophils, T cells, and macrophages (33). Remarkably, a
decreased expression of genes regulating lipid metabolism andFrontiers in Immunology | www.frontiersin.org 12reactive oxygen species was observed in Mdr2−/− C57BL/6 mice,
suggesting an attenuated pathological phenotype as compared to
Mdr2−/− FVB mice. The differences between the two Mdr2−/−
strains in the magnitude of liver inflammation which explain the
differences in the behavior of the strains with respect to
Plasmodium infection strongly support the concept we haveA B
DC
FIGURE 7 | Inoculation of SPZ in Mdr2−/− mice results in a CD8+ and CD4+ effector, central, and tissue resident memory T cell expansion. Six-week-old Female
Mdr2−/− naïve mice, primed mice which received one single dose of 104 SPZ, and two challenged groups of mice which received two additional injections of 104
(group 1) and 105 SPZ (group 2) respectively, at 10 days interval (same protocol as in Supplementary Results: Figure 3), were sacrificed 90 days following the
initial infection with PbANKA parasites (n = 6 per group). Among total liver leukocytes, CD8+ and CD4+ effector and central memory T cells were stained with the
following markers: CD45, CD3, CD8, CD44, CD69, CD62L, and KLRG1. (A) Gating strategy for CD8 Tem (CD3+ CD8+ CD44hi CD69− CD62L−), Tcm (CD3+ CD8+
CD44hi CD69− CD62L+), and Trm (CD3+ CD8+ CD44hi CD69+ CD62L− KLRG1−) among CD45+ cells. (B) Gating strategy for CD4 Tem (CD3+ CD4+ CD44hi CD69−
CD62L−) Tcm (CD3+ CD4+ CD44hi CD69− CD62L+), and Trm (CD3+ CD4+ CD44hi CD69+ CD62L− KLRG1-) among CD45+ cells. Counts of CD3+ CD8+ cells (C) and
CD3+ CD4+ cells (D) analyzed by flow cytometry expressed as percentage (c–e, and k–o) of CD45+ cells and in absolute number of cells (f–j, and p–t). Counts of
CD8+ CD44hi cells (C) and CD4+ CD44hi cells (D), analyzed by flow cytometry, were expressed as percentage (C b, D i) and absolute number of cells (C g, D q) of
CD3+ CD8+ or CD3+ CD4+, respectively. Counts of CD69− CD62L−, and CD69− CD62L+ cells analyzed by flow cytometry expressed as percentage (c, d, and m, n)
and absolute number (h, i, and r, s) of cells of CD3+ CD8+ CD44hi cells (C) or CD3+ CD4+ CD44hi (D). Counts of CD69+ CD62L− KLRG1- cells analyzed by flow
cytometry expressed in percentage (e, o) and absolute number (j, t) of cells of CD3+ CD8+ CD44hi (C) or CD3+ CD4+ CD44hi cells (D). The asterisks indicate
significant differences using the Mann–Whitney test (*p < 0.05; **p < 0.01). Shown data are representative of three independent experiments.November 2020 | Volume 11 | Article 585502
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inflammation and host resistance to Plasmodium infection.
Neutrophils and IL-6 were found to be among the most
discriminative components between WT and Mdr2−/− mice that
are critical in controlling the parasite development. Neutrophils
are essential for maintaining immune surveillance in
homeostatic conditions and can be rapidly recruited in
inflamed tissue under the control of several signals including
CXCR2 and CXCL5. Neutrophil release from the bone marrow is
promoted by increased expression of CXCR2 and its ligands (34)
and IL-6 contributes to the increased mobilization and number
in the periphery (35). In support of this, it has been reported that
IL-6 controls neutrophil trafficking during inflammatory
responses (36) and treatment with anti-IL-6 mAb suppressed
neutrophilic inflammation (37). It is believed that IL-6 promotes
neutrophil influx and survival by stimulating endothelial cells to
secrete IL-8 which contributes to the recruitment of neutrophils
at the site of inflammation (38) and possibly extending
neutrophil half-life by preventing neutrophils from apoptosis
(39). During inflammation, IL-6 was found to be constitutively
stored by murine neutrophils (24, 40) and its secretion upon TLR
ligands is the major inducer of the hepatic acute phase proteins
(41). Related to this, we previously reported that during the pre-
erythrocytic phase, a defect in Plasmodium parasite growth was
caused by an early rise in IL-6 production by neutrophils (24).
Also, work in rodents and cultured hepatocytes showed that
inhibition of liver-stage development was mediated by IL-6 (42,
43). One of the proposed mechanisms by which IL-6 controls
liver infection is by regulating iron homeostasis by hepcidin
(44), which limits Plasmodium development inside
hepatocytes (45).
Having access to an Mdr2−/− and IL-6−/− double knock out
mice in the C57BL/6 background, we could address the relevance
of increased IL-6 response in the defective parasite development
in the liver of Mdr2−/− mice. Evidence for the critical role of IL-6
in the acquisition by Mdr2−/−mice of anti-parasite resistance was
provided by the reversal of the infection phenotype from parasite
blockade in Mdr2−/− C57BL/6 mice to parasite development into
blood stage in Mdr2−/− IL-6−/− double knockout mice. The
current view that emerges from this model, is that the pre-
existing pro-inflammatory environment in the liver of Mdr2−/−
mice becomes enriched in the IL-6 cytokine at the moment
where the tissue receives Plasmodium SPZs and the blockade of
parasite growth is very likely due to effector mechanisms
associated with neutrophils. Neutrophils which respond to IL-6
signaling were also found to produce IL-6 (46), and this
paracrine/autocrine loop may fuel the production of reactive
oxygen species (ROS) which are known to be elevated in Mdr2−/−
mice (47) ultimately resulting in the parasite blockade. As a
bridge between these innate immune signaling pathways and
subsequent adaptive immune responses, IL-6 was shown to
support the growth and enhancement of antibody production
by B cells (48). In support of this, IL-6-deficient mice are
impaired in their IgG production upon immunization (49).
Although IL-6 has been tightly associated to B cell biology as
shown in earlier studies, B cells were found to express onlyFrontiers in Immunology | www.frontiersin.org 13limited levels of IL-6 receptor compared to other leukocytes (50).
Accordingly, IL-6 effects on B cells are due to its indirect effects
on effector T cells, especially Tfh cells (50), and perhaps other T
cell subsets.
IL-6 is critical in regulating CD4 T cell differentiation and
effector cytokine production by promoting IL-4 production
during T cell activation and IL-21 production, an essential
effector cytokine produced by Tfh cells (51, 52). In earlier
studies, IL-6 in combination with IL-7 signaling promotes CD8
memory T cell generation after vaccination (53).
An important question is whether the rapid clearance of SPZ
resulted in the priming of immune cells such as CD8+ T cells
which were previously shown to correlate with protection against
challenge with P. berghei in mice (54) and against irradiation-
attenuated P. falciparum SPZ immunization in humans (55). A
subset of CD8+ T cells, called tissue-resident memory T cells
(Trm), has been identified as sentinels against invading
pathogens, in particular they are capable of recognizing
infected hepatocytes, and their depletion abrogated protection
in mice (56, 57). In the present report, we looked whether, due to
a pro-inflammatory environment in the liver, CD8+ and CD4+
Trm cells are enhanced upon SPZ vaccination in Mdr2−/− mice.
Our results show that not only total CD8+ and CD4+ cells but
also CD8+ and CD4+ Trm cells were present at a significantly
higher levels in SPZ challenged Mdr2−/− mice as compared to
control non challenged mice. Repeated introduction of SPZ in
this inflamed tissue environment dramatically increased and
maintained over a significant amount of time the number of
these cell populations which corresponds to the establishment of
an immune memory.
Although not directly demonstrated in the present work, it is
possible that the inflammatory events associated with
neutrophil-mediated innate immunity may shape the function
of differentiated effector and memory CD4 and CD8 T cells.
Conversely, CD4 and CD8 T cells can promote acute
inflammation by secreting IFN-g and TNF-a which allows the
attraction of neutrophils via the up-regulation of endothelial
adhesion molecules. Interestingly, neutrophils were shown to
pick up and transport antigens to the lymph nodes for CD8 T cell
priming (58) and to the bone marrow for the maintenance of
memory CD8 T cells (59). Thus, neutrophils not only initiate
rapid anti-parasite innate immune responses, but also determine
the specificity and the magnitude of the CD8 T cell responses as
evidenced by a previously unappreciated role for neutrophils as
substrates for cross-priming of CD8 T cell responses against
bacterial antigens (60). Similarly, it was tempting to associate the
early IL-6 signaling in the liver with the parasite clearance and
the subsequent elicitation and expansion of CD4 and CD8+ cells
under the control of IL-6 shown to protect against infections
caused by several pathogens. The failure of parasite development
in Mdr2−/− mice which are completely refractory to infection
even after multiple challenges with high doses of SPZ suggests
that generation of T cells upon a successful vaccination regimen
might have taken place in these mice. To this end, we examined
the generation of CD4 and CD8 effector memory (Tem) and
central memory (Tcm), defined on the basis of the surfaceNovember 2020 | Volume 11 | Article 585502
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priming and challenges of Mdr2−/− mice with SPZ. These two
subsets of memory T cells were previously reported in an
alternative immunization protocol whereby following
radiation-attenuated SPZ immunization, the overall population
of intrahepatic CD8 T cells significantly increases as compared to
naïve mice and protection was linked to both increased CD8
Tem and Tcm (61). In our model, it was striking to observe that
70 days after the last SPZ challenge, in contrast to radiation-
attenuated SPZ immunization protocol, challenged MDR2−/−
mice only maintained a substantially elevated absolute
numbers of CD4 Tcm cells, but not Tcm CD8 cells nor CD8
and CD4 Tem cells. This is also in contrast to P. chabaudi-
infected mice that continue to generate Tem long time after
parasite clearance (62). The discrepancies between these findings
are very likely due to the particular genotype of mice used in our
study and also to the particular inflammatory events taking place
in Mdr2−/− mice.
According to our data, it is tempting to speculate about a
possible impact of contemporaneous liver inflammatory episodes
on malaria transmission and disease progression in individuals
living in endemic areas. In this context, hepatitis B virus (HBV)
infections are very common in many of the malaria endemic
regions. A study in Gambian children showed that impaired
clearance of liver stage parasites may relate to the reduced level of
HLA class I antigen expression on HBV-infected hepatocytes
(63). We believe their interpretation is not valid since loss of
HLA class I antigens would lead to hepatocyte killing by NK cells.
Instead, we suggest that most probably the nature of the
inflammatory response in these infected children may not be
appropriately adjusted to break tolerance and hence parasite
clearance. In another study conducted in the Brasilian Amazon,
Plasmodium parasitemia inversely correlated with HBV viremia,
and HBV infections diminish the intensity of malaria episodes,
and this holds true for both P. falciparum and P. vivax infections
(64). These results were supported by the work of Dabo et al. (65)
who showed reduced parasitemia among subjects with HBV and
malaria co-infection. This is in contrast to another report (66)
which showed that the presence of HBV could significantly
negatively affect the prognosis of malaria infection. The
inconsistencies observed in these human studies may be
related to various limitations, including the lack of available
immunological parameters, and no screen for helminth
infections nor genetic deficiency such as glucose-6 phosphate
dehydrogenase (G6PD) were undertaken.
In conclusion, the introduction for the first time of Mdr2−/−
mice as a mouse model for malaria infection allowed us to
validate the concept that the shift of the naturally tolerant
environment in the liver towards a pro-inflammatory state
promotes an anti-parasite killing and the establishment of an
effective immune memory. This model can be instrumental in
designing new approaches for malaria prevention such as the
development of effective vaccines against pre-erythrocytic stages
of the parasite. In particular, the central position of IL-6 in
determining long term anti-parasite immunity makes feasible the
idea of using the delivery of this cytokine or its up-regulation byFrontiers in Immunology | www.frontiersin.org 14an appropriate means concomitantly with parasite inoculation as
credible vaccine approaches.DATA AVAILABILITY STATEMENT
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